financetom
Business
financetom
/
Business
/
Europe should activate countermeasures against Trump tariffs, lawmaker says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Europe should activate countermeasures against Trump tariffs, lawmaker says
Jul 12, 2025 12:32 PM

BERLIN (Reuters) -A senior European lawmaker said on Saturday Brussels should react immediately with countermeasures against U.S. President Donald Trump's "outrageous" threat to hike tariffs on imports from the European Union.

The EU had been negotiating intensively with Washington for more than three weeks and had made concessions, said Bernd Lange, the head of the European Parliament's trade committee.

The bloc had also suspended all countermeasures after the U.S. imposed an initial tariff of 20% on European imports in April.

"It is brazen and disrespectful to increase the tariffs on European goods announced on April 2 from 20% to 30%," Lange told Reuters.

"This is a slap in the face for the negotiations. This is no way to deal with a key trading partner," he added.

Europe should make it clear that these "unfair trade practices" were unacceptable, Lange said.

"We have postponed the first stage of our countermeasures for the time being, but I am firmly convinced that they must now be implemented immediately," he said.

"The first list of countermeasures must be activated on Monday as planned, and the second list should also follow quickly."

(Reporting by Andreas Rinke, writing by John Revill, editing by Thomas Seythal)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With China Automotive Stock After Posting Lower Product Sales To Stellantis In Q1?
What's Going On With China Automotive Stock After Posting Lower Product Sales To Stellantis In Q1?
May 14, 2024
China Automotive Systems, Inc. ( CAAS ) reported first-quarter earnings per share of 27 cents, up from 23 cents year over year. Net sales were $139.4 million, down 2% year over year. Net sales of traditional steering products and parts were $92 million, down from $94.4 million year over year, while those from electric power steering products and parts were $47.4 million, almost flat. Gross profit increased by 11.6% to $24.1 million. Gross margin...
Market Chatter: Meta Platforms to Shut Down Workplace in 2026
Market Chatter: Meta Platforms to Shut Down Workplace in 2026
May 14, 2024
12:22 PM EDT, 05/14/2024 (MT Newswires) -- Meta Platforms ( META ) plans to shut down its Workplace business communication platform in 2026, TechCrunch reported Tuesday, citing an internal memo and unnamed sources familiar with the matter. Sources told TechCrunch that the company could announce the move later Tuesday. According to the report, the memo said the platform will continue...
Ascent Solar Technologies to Deliver PV Module for Evaluation to Satellite Manufacturer -- Shares Rise
Ascent Solar Technologies to Deliver PV Module for Evaluation to Satellite Manufacturer -- Shares Rise
May 14, 2024
12:22 PM EDT, 05/14/2024 (MT Newswires) -- Ascent Solar Technologies ( ASTI ) said Tuesday it has secured a firm order for its photovoltaics modules for evaluation from a major satellite manufacturer. These modules will be tested for integration into the satellite manufacturer's latest hardware, intended for low Earth orbit. Ascent plans to collaborate with the customer on Plug and...
Update: Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute
Update: Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute
May 14, 2024
12:23 PM EDT, 05/14/2024 (MT Newswires) -- (Updates with Takeda comment in penultimate paragraph.) Scilex Holding ( SCLX ) said Tuesday the US District Court for the District of Delaware approved the settlement between the company, its subsidiary Scilex Pharmaceuticals, and Takeda Pharmaceuticals, resolving a patent infringement lawsuit related to potential gout treatment Gloperba. The company said the US Federal...
Copyright 2023-2026 - www.financetom.com All Rights Reserved